Iliad : After the accumulation, an upward acceleration ?
Entry price | Target | Stop-loss | Potential |
---|
€188.75 |
€198.95 |
€184 |
+5.4% |
---|
After accumulation, acceleration. Timing appears favorable to go long in shares of Iliad and to anticipate an exit of the trading range on the upside.
Strengths● The company returns high margins, thereby supporting business profitability.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● With a 2016 P/E ratio at 27.13 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 198.05 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.